to demonstrate the efficient expansion of human adipose-derived stem cells (hADSC) in stirred-tank bioreactors.
Conducted in collaboration between Promega Corporation and Eppendorf, this study demonstrates the efficient expansion of human adipose-derived stem cells (hADSC) in stirred-tank bioreactors, achieving high cell yields suitable for therapeutic doses. Using microcarriers and controlled bioreactor conditions, the process maintains cell quality and glycolytic metabolism, crucial for regenerative medicine applications. The method ensures reproducibility and scalability, producing metabolically fit cells for cell therapy.